Inovio Pharmaceuticals Q1 Loss Widens as Revenue Drops; Stock Down 5% Late
05:43 PM EDT, 05/10/2021 (MT Newswires) -- Inovio Pharmaceuticals (INO) late Monday reported a Q1 net loss of $0.27 per share, compared with a loss of $0.26 per share in the year-ago quarter.
Analysts polled by Capital IQ were expecting loss of $0.20 per share, on average
Revenue for the quarter ended March 31 fell to $371,120, from $1.3 million in the year-ago period.
Analysts were expecting revenue of $1.06 million.
Shares were down about 5% in the after-hours session.
Price: 6.31, Change: -0.36, Percent Change: -5.40